Nature 590, 140145
Once the medication is stopped, appetite returns to pre-medication levels, and with that change, an increase in caloric intake. It can feel impossible to keep up with the lower calorie intake you might have maintained on a GLP-1 once your appetite and the food noise (a.k.a
Resmetirom received FDA approval for the fibrotic stage, but the steatosis stage, where the vast majority of patients sit, has no approved pharmacological intervention
Time from randomization to first composite kidney event, first composite major cardio-vascular event, and first all-cause death event were analyzed using Cox proportional hazards model, with flozins at baseline used for stratification
For example, Zhang et al (177) developed PMVL, a lonidamine-loaded nanoplatform that enhances ferroptosis and immune activation through dual inhibition of glycolysis and the PPP, effectively reducing lactate production
The difference emerged during follow-up beyond six months, and no significant difference between the two drugs was established for cardiovascular disease risk, although the limited number of cardiovascular events reduced the precision of these estimates